Drugnet Europe, the EMCDDA's quarterly newsletter, provides regular information on the Agency's activities to a broad readership. It is available in print format, PDF and online.
- EN
Stay informed
Media support
To schedule interviews, obtain informed comment, request written contributions or receive the latest news on the agency, please contact our media relations unit:
Kathy Robertson
Head of sector
Media relations and marketing
Tel: (351) 211 21 02 00/32
Fax: (351) 21 813 1711
Maria José Louro
Media relations assistant
Tel: (351) 211 21 02 00/40
Fax: (351) 21 813 1711
Archive of EMCDDA and drug-related news
Drugnet Europe issues
- Drugnet Europe 82 (April–June 2013): PDF format
Summary: In this issue: European Drug Report 2013 highlights | Latest EMCDDA–Europol report on new drugs | Greece and Croatia modify penalties for drug offences | International day against drug abuse and illicit trafficking | Scientific Committee assesses risks of 5-IT | Upcoming European summer school on illicit drugs.
- Drugnet Europe 81 (January–March 2013): PDF format
Summary: In this issue: EU drug markets report highlights; new EU drug strategy endorsed; upcoming risk assessment of 5-IT; European summer school on illicit drugs; call for EU-wide ban on 4-MA; Third international forum on new drugs.
- Drugnet Europe 80 (October–December 2012): PDF format | online version
Summary: In this issue: EMCDDA Annual report 2012 highlights; Selected issues 2012; Wastewater analysis; Reitox academy on building national observatories; EMCDDA and academia; new EMCDDA studies available online.
- Drugnet Europe 79 (July–September 2012): PDF format | online version
Summary: In this issue: market share of herbal cannabis rising; ESPAD survey results; anthrax outbreak among heroin users in Germany; responses to HIV outbreak among IDUs in Greece; new drugs; Kazakhstan study visit; 'Reitox week'; Scientific Director awarded for excellence in international leadership.
- Drugnet Europe 78 (April–June 2012): PDF format | online version
Summary: In this issue: new study on heroin-assisted treatment; second European conference on drug supply indicators; new TDI guidelines; new drugs detected at the rate of around one per week; EMCDDA launches IPA 4; and new EMCDDA products and services.
- Drugnet Europe 77 (January–March 2012): PDF format | online version
Summary: In this issue: 2012 EMCDDA work programme; ECDC-EMCDDA HIV rapid risk assessment; Romania passes law to curb distribution of new psychoactive substances; European summer school on illicit drugs; multicity project on wastewater analysis; upcoming events on new psychoactive substances; and new EMCDDA products and services.
- Drugnet Europe 76 (October–December 2011): PDF format | online version
Summary: In this issue: Annual report 2011 highlights; EMCDDA scientific paper award; ‘Have your say’ in two online surveys; technical cooperation with the Eastern partnership countries; European summer school on illicit drugs; and a new EMCDDA manual on prevention.
- Drugnet Europe 75 (July–September 2011): PDF format | online version
Summary: In this issue: Drugnet Europe reader survey; monitoring wholesale drug prices in Europe; Eurobarometer survey on young people’s attitudes to drugs; call for input in the development of indicators of drug supply in Europe; forum on new drugs — reflections and conclusions; new EMCDDA products and services.
- Drugnet Europe 74 (April–June 2011): PDF format | online version
Summary: In this issue: over 40 new drugs reported in 2010; HIV in the European region; mapping 'drug squads' in Europe; khat use in Europe; new EMCDDA products and services.
- Drugnet Europe 73 (Jan–March 2011): PDF format | online version
Summary: In this issue: mephedrone ban across the EU; Poland passes new law to control ‘head shops’ and ‘legal highs’; a new European Society for Prevention Research; 2011 EMCDDA work programme; a new prize for top scientific papers; new EMCDDA products and services.
- Drugnet Europe 72 (October–December 2010): PDF format | online version
Summary: In this issue: Annual report 2010 highlights — ‘old realities, new threats and economic austerity’ plus Ireland passes new law to control ‘head shops’ and ‘legal highs’; new handbook on building a national drugs observatory; training manual for prison staff and harm reduction; and a new EMCDDA-CICAD three-year work programme.
- Drugnet Europe 71 (July–September 2010): PDF format | online version
Summary: In this issue: injecting drug use stable or declining; early-warning system annual meeting; EU scientific experts to assess risks of mephedrone; harm reduction moves to the mainstream; EMCDDA and EMA step up cooperation; European technical conference on drug supply indicators coming up; EMCDDA-CICAD cooperation; new products and services.
- Drugnet Europe 70 (April–June 2010): PDF format | online version
Summary: In this issue: record number of new drugs in 2009; EMCDDA and ECDC assess anthrax outbreak among heroin users; global audit of HIV services for IDUs reveals low levels of provision; sharing information on drug treatment demand in the Mediterranean; drug use and pregnancy — challenges for public health; latest analysis of cocaine market highlights 'secondary extraction' laboratories in Europe; new products and services.
- Drugnet Europe 69 (January–March 2010): PDF format | online version
Summary: In this issue: 2010 work programme and budget; EMCDDA and Europol step up information collection on mephedrone; upcoming Guidelines for collecting data on retail drug prices in Europe; European drug prevention quality standards; EMCDDA signs accord with Ukrainian Ministry of Health; new Czech penal code enters into force; EMCDDA Management Board – changes at the helm; new products and services.
- Drugnet Europe 68 (October–December 2009): PDF format | online version
Summary: EMCDDA releases Annual report 2009; Selected issues 2009: Drug offences: sentencing and other outcomes and Polydrug use: patterns and responses; EMCDDA-CARDS project with the Western Balkans; Bridging the research gap in the field of illicit drugs in the EU.
- Drugnet Europe 67 (July–September 2009): PDF format | online version
Summary: Brain research throws light on addiction; European action on drugs; Associations between HIV-prevention measures and HIV infection; globalisation and harm reduction; World drug report 2009; European Commission conference on drug-related research.
- Drugnet Europe 66 (April–June 2009): PDF format | online version
Summary: 15 years of drug monitoring in Europe; new European study on Internet-based drug treatment; ESPAD, a crucial window onto adolescent substance use; EMCDDA and Europol step up cooperation; World drug policy: priorities for the next decade.
- Drugnet Europe 65 (January–March 2009): PDF format | online version
Summary: concerns expressed over Spice; latest findings on measuring illicit drugs in wastewater and on drugs and driving; legal responses to new psychoactive substances in Europe; new thematic paper on indicated prevention and a drug profile on BZP.
- Drugnet Europe 64 (October–December 2008): PDF format | online version
Summary: Annual report 2008 with the latest on the drugs problem across Europe; drugs and vulnerable groups of young people; national drug-related research in Europe; towards a new EU drugs action plan; country overviews; and new EMCDDA products and services.
- Drugnet Europe 63 (July–September 2008): PDF format | online version
Summary: Eurobarometer study on young people and drugs; cross-country collaboration in scientific publishing; civil society and EU policymaking on drugs; and new EMCDDA products and services (including a cannabis reader, report on public expenditure, and the launch of the EMCDDA publications database and Fonte).
- Drugnet Europe 62 (April–June 2008): PDF format | online version
Summary: Drug problems have no age limits; emerging use of GBL; monitoring drug-facilitated sexual assault; estimating the total burden of drug-related mortality and new EMCDDA products and services.
- Drugnet Europe 61 (January–March 2008): PDF format | online version
Summary: Outcome of the external evaluation; the selection of the new Scientific Committee; EMCDDA and ESPAD cooperation; and the kick off for the technical assistance project with the Western Balkans.
- Drugnet Europe 60 (October–December 2007): PDF format | online version
Summary: Launch of the 2007 Annual report and Selected issues; the signing of a Memorandum of Understanding between the EMCDDA and the Russian drugs service; and the new partnership between the EMCDDA and the Western Balkans
- Drugnet Europe 59 (July–September 2007): PDF format | online version
Summary: Priorities of the current Portuguese Presidency of the EU in the field of drugs; the ongoing evaluation of the EMCDDA; the launch of the agency's new data tool 'Fonte'; and the role of local authorities in tackling drugs.
- Drugnet Europe 58 (April–June 2007): PDF format | online version
Summary: A new project for screening for problem cannabis use; how the EMCDDA is supporting the 2008 UNGASS review; how to participate in the evaluation of the EMCDDA; and details of forthcoming cooperation agreements, literature reviews and policy briefings.
- Drugnet Europe 57 (January–March 2007): PDF format | online version
Summary: 'How effective is the EMCDDA?' is one of the questions posed in the latest edition of Drugnet Europe in the context of an ongoing evaluation of the agency. Now readers of the newsletter are given the chance to 'have their say'. Also covered in this edition are the new remit of the EMCDDA and its new work programmes. Upcoming products are also showcased including a new series of drug profiles and a drug treatment demand toolkit.
- Drugnet Europe 56 (October-December 2006)
- Drugnet Europe 55 (July-September 2006)
- Drugnet Europe 54 (April-June 2006)
- Drugnet Europe 53 (January-March 2006)
- Drugnet Europe 52 (October-December 2005)
- Drugnet Europe 51 (July-September 2005)
- Drugnet Europe 50 (April-June 2005)
- Drugnet Europe 49 (January-March 2005)
- Drugnet Europe 48 (October-December 2004)
- Drugnet Europe 47 (July-September 2004)
- Drugnet Europe 46 (April-June 2004)
- Drugnet Europe 45 (January-March 2004)
- Drugnet Europe 44 (November-December 2003)
- Drugnet Europe 43 (September-October 2003)
- Drugnet Europe 42 (July-August 2003)
- Drugnet Europe 41 (May-June 2003)
- Drugnet Europe 40 (March-April 2003)
- Drugnet Europe 39 (January-February 2003)
- Drugnet Europe 38 (November-December 2002)
- Drugnet Europe 37 (September-October 2002)
- Drugnet Europe 36 (July-August 2002)
- Drugnet Europe 35 (May-June 2002)
- Drugnet Europe 34 (March-April 2002)
- Drugnet Europe 33 (January-February 2002)
- Drugnet Europe 32 (November-December 2001)
- Drugnet Europe 31 (September-October 2001)
- Drugnet Europe 30 (July-August 2001)
- Drugnet Europe 29 (May-June 2001)
- Drugnet Europe 28 (March-April 2001)
- Drugnet Europe 27 (January-February 2001)
- Drugnet Europe 26 (November-December 2000)
- Drugnet Europe 25 (September-October 2000)
- Drugnet Europe 24 (July-August 2000)
- Drugnet Europe 23 (May-June 2000)
- Drugnet Europe 22 (March-April 2000)
- Drugnet Europe 21 (January-February 2000)
- Drugnet Europe 20 (November-December 1999)
- Drugnet Europe 19 (September-October 1999)
- Drugnet Europe 18 (July-August 1999)
- Drugnet Europe 17 (May-June 1999)
- Drugnet Europe 16 (March-April 1999)
- Drugnet Europe 15 (January-February 1999)
- Drugnet Europe 14 (November-December 1998)
- Drugnet Europe 13 (September-October 1998)
- Drugnet Europe 12 (July-August 1998)
- Drugnet Europe 11 (May-June 1998)
- Drugnet Europe 10 (March-April 1998)
- Drugnet Europe 9 (January-February 1998)
- Drugnet Europe 8 (November-December 1997)
- Drugnet Europe 7 (September-October 1997)
- Drugnet Europe 6 (July-August 1997)
- Drugnet Europe 5 (May-June 1997)
- Drugnet Europe 4 (March-April 1997)
- Drugnet Europe 3 (January-February 1997)
- Drugnet Europe 2 (November-December 1995)
- Drugnet Europe 1 (September-October 1995)
Page last updated: Monday, 17 June 2013